Harvard Bioscience (HBIO) Misses Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Harvard Bioscience Reports Third Quarter 2015 Financial Results and Updates Outlook for Full-Year 2015
October 29, 2015 6:30 AM EDTHOLLISTON, Mass., Oct. 29, 2015 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, reported financial results for the three and nine months ended September 30, 2015.
The Company reported revenues for the third quarter of $25.7 million and non-GAAP diluted earnings per share of $0.03. This compares with revenue of $25.4 million and non-GAAP earnings per diluted share of $0.06 reported in the year-ago quarter. For a reconciliation between the GAAP and non-GAAP net income, refer to Exhibits 5 and 6 below. Excluding currency translation, revenues increased 4%... More
Harvard Bioscience Reports Third Quarter 2015 Financial Results and Updates Outlook for Full-Year 2015
October 29, 2015 6:30 AM EDTHOLLISTON, Mass., Oct. 29, 2015 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, reported financial results for the three and nine months ended September 30, 2015.
The Company reported revenues for the third quarter of $25.7 million and non-GAAP diluted earnings per share of $0.03. This compares with revenue of $25.4 million and non-GAAP earnings per diluted share of $0.06 reported in the year-ago quarter. For a reconciliation between the GAAP and non-GAAP net income, refer to Exhibits 5 and 6 below. Excluding currency translation, revenues increased 4%... More
